Clinical Trials Logo

Arthritis clinical trials

View clinical trials related to Arthritis.

Filter by:

NCT ID: NCT00072657 Completed - Clinical trials for Rheumatoid Arthritis

Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis

Start date: February 2004
Phase: N/A
Study type: Interventional

Rheumatoid arthritis (RA) is a chronic illness. Patients with RA often experience significant pain and depression. This study will evaluate two programs designed to improve the symptoms of RA: cognitive-behavioral therapy (CBT) and Tai Chi Chih (TCC), compared to a health education seminar.

NCT ID: NCT00071812 Completed - Clinical trials for Arthritis, Rheumatoid

A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)

Start date: December 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of 3 different doses of belimumab, administered in addition to standard therapy, in patients with rheumatoid arthritis (RA).

NCT ID: NCT00071292 Completed - Clinical trials for Rheumatoid Arthritis

Meditation-Based Stress Reduction in Rheumatoid Arthritis

Start date: July 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).

NCT ID: NCT00071149 Completed - Clinical trials for Rheumatoid Arthritis

Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis

Start date: November 2001
Phase: N/A
Study type: Observational

Practitioners of Traditional Chinese Medicine (TCM) make diagnoses based solely on clinical symptoms. This study will evaluate whether TCM practitioners make diagnoses consistently.

NCT ID: NCT00069472 Completed - Clinical trials for Rheumatoid Arthritis

Genetic Registry for Rheumatoid Arthritis

NARAC
Start date: October 2002
Phase: N/A
Study type: Observational

Many genes are thought to contribute to rheumatoid arthritis (RA). This study will attempt to identify genes that may contribute to RA.

NCT ID: NCT00069342 Completed - Clinical trials for Rheumatoid Arthritis

Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases

Start date: September 22, 2003
Phase:
Study type: Observational

This study will explore the diverse health beliefs and behaviors among minority patients with rheumatic diseases. These diseases may cause joint pain, stiffness or swelling. Some can involve bones, muscles, tendons or ligaments. Some cause abnormalities of the immune system-the body's defense against disease. Some rheumatic diseases are painful or deforming and some can be life-threatening. Many rheumatic diseases occur more often and more severely in certain minority communities. This study will explore psychosocial and cultural factors related to rheumatic disease in minorities. Patients enrolled in the NIAMS protocol Natural History or Rheumatic Disease in Minority Communities (protocol #01-AR-0227) may participate in this study. Participants will be evaluated at the NIAMS Community Health Center at the Upper Cardozo Health Center in Washington, D.C. Participants will be interviewed about individual and community health behavior, and health beliefs about rheumatic disease and its effects on several areas of their life, including mood and physical activity. The interview will be in one of the following formats: 1) in-depth cognitive interview, 2) focus group, or 3) face-to-face interview, as follows: In-Depth Cognitive Interview Participants take part in a one-time interview conducted by one investigator, observed by another, and tape recorded. The interview lasts from 1 to 2 hours. Focus Groups Participants take part in a group interview of from 6 to 10 people during a one-time tape-recorded session that lasts from 2 to 2-1/2 hours. The group discussion is led by a moderator and a facilitator, who takes notes and makes observations. Face-to Face Interview Participants are interviewed twice - first upon enrollment at the NIAMS Community Health Center and again after 6 months' follow-up at the Center.

NCT ID: NCT00069017 Completed - Clinical trials for Rheumatoid Arthritis

Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate

Start date: September 2003
Phase: Phase 2
Study type: Interventional

To compare, as a preliminary analysis, the effects of MEDI-522 versus placebo at 6 months on disease activity (ACR20) and progression of structural joint damage.

NCT ID: NCT00067249 Completed - Depression Clinical Trials

Women's Use of Alternative Medicine: A Multiethnic Study

Start date: April 2001
Phase: N/A
Study type: Observational

The purpose of this study is to examine socio-cultural factors of women’s use of complementary and alternative medicine (CAM). The effects of socioeconomic status, social networks and acculturation on CAM use will be assessed among white, African-, Mexican-, and Chinese-American women.

NCT ID: NCT00062465 Completed - Clinical trials for Rheumatoid Arthritis

Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine

Start date: June 2003
Phase: Phase 2
Study type: Interventional

Various forms of the plant extract Tripterygium wilfordi Hook F (TwHF) have been used in China as a remedy for inflammatory diseases, including rheumatoid arthritis. The purpose of this study is to investigate how tolerable, safe, and effective TwHF is for patients with rheumatoid arthritis. Investigators will compare the therapeutic effects of TwHF with Sulfasalazine, an FDA-approved drug for arthritis. Participants in this 24-week study must have had active rheumatoid arthritis for at least six months. Approximately 120 patients will participate. Participants will be assigned to one of two drug-treatment groups, TwHF or Sulfasalazine. They will be given the study drug at each of six clinic visits and will be asked to take two capsules three times each day with meals and water. During the clinic visits, investigators will obtain multiple blood samples; give physical exams; assess swollen, tender, and painful joints; and administer x-rays. Study participants will be compensated up to $260 for their involvement in this study.

NCT ID: NCT00056667 Completed - Clinical trials for Rheumatoid Arthritis

Relaxation Response Training for the Treatment of Rheumatoid Arthritis

Start date: July 2001
Phase: Phase 4
Study type: Interventional

This study will evaluate the relative effectiveness of Relaxation Response (RR) training for the treatment of rheumatoid arthritis (RA). The study will compare RR training to RR training with cognitive behavioral therapy and to a standard RA education program.